Multicenter,Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as MonotherapyorFirst Adjunctive Therapy in SubjectsWith Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic
Administered By
Awarded By
Contributors
- Sinha, Saurabh Ranjan Principal Investigator
Start/End
- March 13, 2018 - October 22, 2021